In both tumor cell lines, pretreatment with the pan-caspase inhibitor, or with preferential caspase-inhibitors for caspases -9, -8, -3 and -7, reduced the cytotoxicity of SAHA and TRAIL, indicating the involvement of these caspases. Here, CASP9 is linked to neoplasm.